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Introduction  The automated breast volume scanner (ABVS) is the 
fi  rst of its kind and utilises a large, 17 cm × 15 cm high-frequency 
ultrasound probe which sweeps across the whole breast generating 
images that can be reformatted into multiple planes and a 3D volume. 
ABVS will change breast ultrasound practice by: introducing operator 
standardisation, reproducibility and repeatability of measurement 
and interpretation; changing who acquires the volume set and how 
breast ultrasounds are reported; and allowing accurate comparison 
of previous and current examinations for screening and assessing 
treatment change.
Methods Patients presented to the symptomatic clinic for conventional 
2D ultrasound assessment with a variety of conditions. An additional 
ABVS was performed.
Results  Cases were classifi   ed into: benign – for example, cysts, 
fi  broadenomas, diabetic mastopathy; and malignant.
Conclusion We present a review of our initial experience and highlight 
its advantages over conventional ultrasound, which include: improved 
mapping of lesions enabling more accurate future assessment and 
follow-up, and improved assessment of distortion over conventional 
2D ultrasound. Further research is required to explore other potential 
benefi  ts.
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Symptomatic breast services in Ireland: how do they compare with 
national and international standards?
D O’Leary, L Rainford
UCD, School of Medicine and Medical Science, Dublin, Ireland
Breast Cancer Research 2011, 13(Suppl 1):O2 (doi: 10.1186/bcr2948)
Introduction  A study of symptomatic breast units geographically 
spread over Ireland collected image quality, compression and radiation 
dose data from 18 mammography units; so how do these optimisation 
parameters compare nationally and internationally? The mean 
glandular dose (MGD) diagnostic reference level was proposed for 
the all-digital breast screening service [1] but not for the symptomatic 
breast service.
Methods The quantitative and qualitative data were analysed using 
SPSS. Recommendations of MGD diagnostic reference levels were 
made at various levels for fi   lm-screen mammography (FSM) and 
full-fi  eld digital mammography (FFDM) units to match those levels 
published in worldwide.
Results MGDs received by symptomatic breast patients within Ireland 
are higher than those received in the all-digital Irish Breast Screening 
service, although the diff  erences for FFDM are not substantial; 55 to 
65 mm breast: 1.75 mGy (screening) versus 2.4 mGy (symptomatic) at the 
95th percentile. The four-view routine mammography MGDs obtained 
in symptomatic breast units in Ireland are, however, substantially 
diff  erent from other screening units with mixed FSM/FFDM modalities: 
4.5 mGy (UK); 4.98 mGy (USA) versus 5.96 mGy (FFDM, symptomatic) 
and 9.63 mGy (FSM, symptomatic). Various reasons are proposed for 
the diff  erences.
Conclusion  MGD diagnostic reference levels achieved in the 
screening service may be lower due to the exacting requirements for 
radiographer training, nonsurgical alteration of patient breasts and 
equipment quality assurance levels. Greater training of radiographers 
performing mammography in the symptomatic breast services is 
required to standardise mammographic projections with regard to 
MGDs delivered.
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Introduction Shear wave elastography is a new ultrasound technique 
which shows promise in the diff  erential diagnosis of solid breast masses. 
This study compares the mean tumour stiff  ness with mammographic 
fi  ndings and mammographic density in women with invasive breast 
cancer.
Methods Mammographic morphological features and BIRADS density 
assessment of the contralateral breast were documented in 96 
consecutive patients with operable invasive breast cancer who had 
undergone shear wave elastography. Mammographic assessment was 
performed blinded to the elastography and pathological fi  ndings. Mean 
stiff  ness values of individual tumours were classifi  ed as either above 
or below the average mean stiff  ness of the cancers. Chi-squared tests 
for trend were used to compare mean stiff  ness with mammographic 
features and density.
Results There was no statistically signifi  cant diff  erence in the mean 
stiff   ness of tumours according to their mammographic features. 
Mean tumoural stiff  ness increased with breast density (average mean 
stiff  ness 126 kPa, 132 kPa, 154 kPa, and 179 kPa for BIRADS densities 1 
to 4, respectively), with a statistically signifi  cant trend of stiff  ness being 
above average for a cancer in a denser breast. No statistically signifi  cant 
correlation was shown between tumour size or grade (factors known 
to be associated with increased stiff  ness) and mammographic density.
Conclusion Tissue stiff  ness of breast cancers is greater in women with 
mammographically denser breasts. Assuming elastographic stiff  ness 
refl  ects characteristics of stroma and tumour, our fi  ndings suggest that 
tumour–stroma interactions may vary with mammographic density. © 2010 BioMed Central Ltd
Royal College of Radiologists Breast Group Annual 
Scientifi  c Meeting 2011
Glasgow, UK, 7-8 November 2011
Published: 4 November 2011
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Full-fi  eld digital mammography: a retrograde step for small screen-
detected cancers?
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Introduction Our breast surgery service receives many breast cancer 
referrals from neighbouring breast screening centres with analogue 
mammography systems. As hospital protocol we perform repeat full-
fi  eld digital mammography (FFDM) in these women in an attempt to 
better stage the primary tumours. The aim of this study is to assess 
whether FFDM detects more disease than analogue mammography 
in patients with screen-detected cancer with pathological correlation.
Methods Three experienced mammography readers evaluated repeat 
FFDM in 60 women whilst blinded to the prior analogue studies. Sixty 
age-matched controls were also assessed. The mammographic fi  ndings 
were then compared with the fi  nal surgical pathology. Breast density 
scores were recorded using Quantra™ software to assess whether this 
infl  uenced diagnostic accuracy.
Results  Sixteen (26.7%) analogue mammography-detected cancers 
were not detected by at least one reader on FFDM. Three (5%) analogue 
mammography-detected cancers were missed by all three readers on 
FFDM. Small soft tissue masses represented all of the cancers missed 
by all three readers. Mean fi   broglandular density as assessed by 
Quantra™ was 15.3 for controls, 13.9 for cancers and 14.2 for cancers 
not identifi  ed by at least one reader. FFDM more accurately staged 
the DCIS extent than analogue mammography when comparing fi  nal 
surgical pathology, although the result was not signifi  cant (P = 0.2).
Conclusion Not all cancers visualised on analogue mammography can 
be seen on repeat FFDM performed within 2 weeks, even allowing for 
biopsy-related bruising. Although DCIS is possibly better staged by 
FFDM compared with analogue, small soft tissue masses are less well 
distinguished. This eff  ect does not seem related to background breast 
density.
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Introduction It is widely accepted that there is an association between 
mammographic density and breast cancer risk [1]. Various studies have 
examined relationships between ethnicity and breast density patterns 
using the Wolfe classifi  cation system [2], with a view to investigating 
potential breast cancer risk. Quantra™ is a volumetric assessment tool, 
which allows reproducible objective measurement of mammographic 
breast density, eliminating inter-observer variability. Our study sought 
to investigate the correlation between ethnicity and breast density 
using Quantra™ measurements.
Methods The Quantra™ value was recorded from the mammograms 
of symptomatic breast patients at St George’s Hospital, London over 
a 6-month period. We compared three distinct ethnic groups; Black 
(African and Afro-Caribbean), Asian (Indian subcontinent) and White 
(Caucasian). Mean Quantra™ values were calculated for each group and 
the Kruskal–Wallis test was applied.
Results A total of 428 patients were included in the study. Mean breast 
density values for the three ethnic groups were as follows: Black, 
24.31%; Asian, 21.94%; White, 24.74%. P = 0.0046 (Kruskal–Wallis).
Conclusion There is a statistically signifi  cant diff  erence between the 
objectively measured breast densities of these three ethnic groups. 
This is of relevance to the assessment of breast cancer risk.
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Introduction  Supplementary views (SV) are routinely used in the 
diagnostic workup of mammographic lesions. Previous studies have 
demonstrated that digital breast tomosynthesis (DBT) increases the 
accuracy of classifi  cation of mammographic lesions [1]. In this study 
the diagnostic accuracy of SV is compared with DBT.
Methods The study included cases from screening assessment and 
symptomatic clinics requiring further mammographic workup. The 
cases were read by seven specialist breast radiologists. In the fi  rst 
session, readers read bilateral two-view full-fi  eld digital mammography 
(FFDM) and SV of the lesion. In the second session, at least 1 week later, 
readers read bilateral two-view FFDM plus one-view DBT in the same 
projection as the SV. Mammographic scores (1 to 5), lesion type and 
fi  nal outcome were recorded.
Results A total of 356 cases were assessed using receiver operative 
characteristic analysis to evaluate the diff  erence between the two 
modes. For FFDM plus SV, the area under the curve (AUC) was 0.8807 
(95% CI = 0.84374 to 0.91766) and for FFDM plus DBT the AUC was 
0.9186 (95% CI = 0.88821 to 0.94895); diff  erence in AUCs was 0.0379 
with P value 0.055.
Conclusion These results demonstrate that the accuracy of DBT has 
borderline superiority to SV in the diagnostic workup of mammographic 
lesions.
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A Coltart1, C Blythe2, M Hair3
1South West of Scotland Breast Screening Unit, Irvine, UK; 2Queen Margaret 
University, Edinburgh, UK; 3Ayrshire and Arran Health Board, Kilmarnock, UK
Breast Cancer Research 2011, 13(Suppl 1):P1 (doi: 10.1186/bcr2953)
Introduction In 2009, the South West of Scotland Breast Screening 
Unit (SWSBSU) had to repeat 236 examinations due to mammographic 
image unsharpness. Such recalls were undesirable because of radiation 
safety issues, anxiety caused and cost. The aim of this study was to 
model predictors of recall that could be used in clinical practise to help 
reduce the numbers of repeat examinations required due to blurring.
Methods  This retrospective study compared two sample groups 
(n = 118), randomly selected from a cohort of women who attended 
the SWSBSU in 2009 (n = 16,194). Tests of signifi  cance were used to 
compare a range of variables in each group and logistic regression 
was employed to produce four predictor models for recall. Statistical 
analysis was carried out by the authors using SPSS version 18.
Results A 12 mm increase in compressed breast thickness (CBT), a 
50 mAs increase in exposure or a 350 ms increase in exposure time will 
double the odds of recall due to unsharpness. Also, an increase of 2 kVp, 
when imaging a breast with a CBT of 60 mm, will reduce the odds of 
recall by approximately 39%.
Conclusion CBT is a major determinant of recall due to unsharpness. 
Within the context of the reported increase in average CBT [1] and 
rising national obesity, reconsideration of kVp selection criteria may be 
necessary to minimise the incidence of recall due to unsharpness.
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Introduction Needle core biopsy (NCB) is frequently used in assessing 
screen-detected breast lesions. Uncertainty remains over appropriate 
management of NCBs reported as ‘uncertain malignant potential’ (B3) 
or ‘suspicious of malignancy’ (B4). This study aims to analyse a large 
screening dataset to establish positive predictive values (PPVs) for 
malignancy on excision biopsy, for diff  erent classifi  cations of B3 and 
for B4 NCBs.
Methods  Retrospective analysis was conducted of prospectively 
collected data for South East London Breast Screening Service. A total 
of 5,324 patients underwent NCB between 2000 and 2010, including 
14G (ultrasound-guided) and 10G vacuum-assisted biopsies (stereo-
guided). A total of 444 were B3 (8.3%) and 38 (0.7%) were B4. NCBs 
reported as B3 were classifi  ed by pathological subtype and PPVs for 
malignancy calculated for each subtype. Outcomes following B4 NCB 
were also assessed.
Results The overall PPV for malignancy for B3 NCBs was 25% and for B4 
NCBs was 74%. The PPVs for each subtype of B3 classifi  cation were as 
follows: papillary 14%, atypical intraductal epithelial proliferation 35%, 
phyllodes 11%, lobular 47%, complex sclerosing lesion/radial scar 6%, 
columnar cell 29%.
Conclusion  Our fi  ndings indicate that NCBs reported as B4 should 
be excised as they have a high likelihood of malignancy on excision 
biopsy. The PPVs for subtypes of B3 NCBs vary considerably. However, 
B3 subtypes with atypia should be treated with a higher level of 
suspicion and preferably be surgically excised. Decisions regarding 
further assessment should be made in a multidisciplinary setting.
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Introduction Objective critique of mammographic image quality (IQ) is 
vital to assess effi   cacy of services provided by mammography units. The 
European Guidelines for Screening Mammography require an inadequate 
image rate of 3%. The subjectivity within current IQ criteria allows 
symptomatic mammograms with surgically altered breasts to appear 
to achieve these requirements; however, as evidenced in the analysis of 
symptomatic breast images within a national optimisation study, current 
methods of classifi   cation for symptomatic mammograms are largely 
subjective, resulting in poor inter/intra-departmental agreement on IQ.
Methods The European Quality Criteria for mammographic IQ and the 
Breast Screening quality criteria classifi  cation of images as inadequate/
moderate/good/perfect were modifi   ed to remove all subjective 
criteria. These objective classifi  cations of IQ were tested for inter/intra-
rater reliability by a panel of experts and compared with original IQ 
criteria. Further objective measures such as breast volume, density and 
pectoral–nipple measurements were carried out.
Results When tested with 278 surgically modifi  ed breast images from 
the larger research sample, inter-rater reliability (K >0.701; P <0.001) and 
agreement (Pearson’s correlation r >0.884; P <0.01) by the evaluation 
panel were higher than when the original quality criteria methods were 
used. The intra-rater reliability was equally high (K >0.7; P <0.001) with 
agreement via Pearson’s correlation at r >0.844; P <0.01.
Conclusion A method of scoring images combining the most objective 
components of major European, national and international image 
scoring systems is suggested. The removal of subjectivity from the 
scoring systems will remove all doubt regarding the achievement of 
high image-quality goals for all mammography departments.
P4
Comparison of analogue and digital mammographic appearances 
of screen-detected invasive breast cancers
TW Jones, G Bansal, H Farmer, B Orr, H Russell, L Hobson, D Godden, 
I Lyburn
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Introduction  Our UK Breast Screening Service changed overnight 
wholesale from analogue to digital mammography on 5 October 2009. 
This has meant that we have two unmixed cohorts to directly compare. 
We wish to evaluate whether any digital mammography has changed 
our cancer detection, and whether any features of these cancers have 
altered.
Methods A NBSS database search for all screen detected cancers in 
the periods 1 year prior to the digital changeover; and 1 year after. 
This period was suffi   ciently historical to expect all cancer diagnosis 
episodes to have closed by the time of study. The screening packets for 
all these patients were pulled, and fi  lms and pathology analysed by the 
researchers. The information was directly entered into an anonymised 
spreadsheet.
Results  For  2008 to 2009 analogue: 24,876 women invited, 20,557 
screened, 944 recalled for assessment, 155 diagnosed with cancer; 
mean age 59.7. For 2009 to 2010 digital: 32,143 women invited, 25,088 
screened, 1,230 recalled for assessment, 221 diagnosed with cancer; 
mean age 61.0.
Conclusion Screening uptake fi  gures were high in this unit (78% and 
82% for each group). Cancer detection rates were signifi  cantly increased 
in the age 50 to 64 group (analogue 4.6 and digital 6.2/1,000 women 
screened). Mean cancer sizes were smaller on digital mammography 
but this also corresponded with smaller mean pathological sizes. 
Adjusting for this, the digital system still identifi  ed smaller cancers than 
the analogue system. Overall, cancer detection seems improved by our 
change to digital mammography.
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Apparent diff  usion coeffi   cient of normal breast tissue during the 
menstrual cycle at 3 Tesla
N AlRashidi, T Ahearn, B Jagpal, T Redpath, F Gilbert
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Introduction  Diff   usion-weighted magnetic resonance imaging (DW-
MRI) is a quantitative MRI technique that provides physiological 
information by measuring the degree of water molecule diff  usion within 
the extracellular space. It gives a quantitative measurement known as 
the apparent diff  usion coeffi   cient (ADC) value. The aim of the study is to 
show the infl  uence of the menstrual cycle on breast ADC values and the 
relationship of the ADC to transverse relaxation (T2) value.
Methods Female volunteers had one MRI scan per week over 4 weeks 
using a 3 T MRI scanner. The ADC of the fi  broglandular tissue was 
measured using a single-shot SE-EPI with four b values (0, 50, 150, and 
800 s/mm2). The T2 relaxation time was measured using T2w turbo spin 
echo (TSE) with four echo times (20, 40, 60, and 80 ms). ADC and T2 
maps were generated automatically by standard Philips software.
Results  The study was performed on 11 healthy volunteers (23 to 
41 years old) with a regular menstrual cycle. There is no signifi  cant 
diff  erence between ADC and T2 values for the 4 weeks. Pearson’s 
correlation coeffi   cient indicated a negative correlation between ADC 
and T2 values. See Table 1.
Conclusion The study shows that ADC values are not aff  ected by the 
normal hormonal fl  uctuations during the menstrual cycle.
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Quantifi  cation of breast cancer risk based on the UK fi  ve-point 
classifi  cation system
D Tzias, S George, L Wilkinson, R Mehta
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Introduction The UK fi  ve-point classifi  cation for radiological assessment 
of mammograms and ultrasound scans broadly enables evaluation of 
cancer risk [1], but no specifi  c probabilities are incorporated into this 
system. By comparison, the widely accepted BI-RADS scoring system 
does include percentage cancer risk for each category [2]. Our study 
sought to investigate the cancer probability for each of the fi  ve 
radiological grades in the UK scoring system amongst a large group of 
mammograms.
Methods  The reports of 3,149 mammograms performed over a 
10-month period within the symptomatic breast service at St George’s 
Hospital, London were analysed. The corresponding histopathology 
reports were collected for identifi  cation of malignant cases. Percentage 
cancer risk was calculated for each category within the UK fi  ve-point 
classifi  cation system.
Results  The pathology reports corresponding to each of the 3,149 
mammograms revealed 78 cases of malignancy. Data analysis gave the 
following cancer probabilities for each category: M1, 0.3%; M2, 0.6%; 
M3, 13.5%; M4, 63.6%; and M5, 83.0%.
Conclusion We propose that calculation of cancer risk for each category 
within the UK fi  ve-point scoring system is a valuable parameter. It 
enables accurate performance monitoring within a breast unit as well 
as comparison with national/international standards.
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Ultrasound staging and fi  ne needle aspiration cytology: how well 
do they predict breast cancer nodal involvement?
JM Schneider1, A Leaver2
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Introduction Ultrasound and fi  ne needle aspiration cytology (FNAC) 
are used to provide presurgical axillary assessment in breast cancer, in 
line with NICE guidance. An N1 to N5 ultrasound staging process has 
been recently introduced. The signifi  cance of the new N staging system 
and overall preoperative staging results has been analysed.
Methods  Patient data were collected during MDTs and from the 
electronic results and analysed retrospectively. Patients with ultrasound 
score N and/or axillary FNAC were included if they had subsequent 
histology (sentinel lymph node biopsy or axillary clearance).
Results A total of 125 patients had histological node samples following 
ultrasound assessment and/or FNAC. Fifty-eight had both ultrasound 
and FNAC. Ultrasound/FNAC were found to be 82% (27/33)/79% (23/29) 
sensitive and 100% (44/44)/100% (41/41) specifi  c, respectively. The 
overall preoperative staging process sensitivity was 65%. The positive 
predictive values of N3, N4, and N5 were 31% (10/32), 50% (6/12) and 
100% (11/11), respectively.
Conclusion  Combining ultrasound and FNAC assessment provides a 
valuable method of preoperative lymph node staging, guiding surgical 
management, reducing unnecessary surgery and the number of repeat 
operations. Our ultrasound N staging system correlates well with fi  nal 
histology, and we now plan to introduce repeat axillary biopsy with 
high stage N/negative FNAC patients, to attempt an overall increase in 
preoperative staging sensitivity/a more eff  ective management pathway.
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Incidence and outcome of 18-fl  uorodeoxyglucose positron emission 
tomography/computed tomography-detected breast lesions
LS Haine, G Rutherford, CE Ingram, IJ Jolley, O Hatsiopoulou
The Royal Hallamshire Hospital, Sheffi   eld, UK
Breast Cancer Research 2011, 13(Suppl 1):P9 (doi: 10.1186/bcr2961)
Introduction Breast cancer accounts for around 16% of female deaths 
in the UK. Usual diagnosis is via the symptomatic pathway or screening. 
Positron emission tomography/computed tomography (PET/CT) is 
a modality with increasing applications in staging malignancies and 
investigating symptoms. It increasingly detects incidental breast 
lesions. The aim of this study was to evaluate the incidence and 
outcome of PET/CT-detected breast abnormalities.
Methods The radiology information server (CRIS) was interrogated to 
produce a list of PET/CT scan results containing the word ‘breast’ over 
4 years. Scans performed on patients with known breast malignancy 
were excluded. A further CRIS search was used to determine if 
subsequent breast imaging was performed. Pathology was obtained 
and hospital notes were reviewed.
Results Thirty patients were found to have incidental breast lesions 
on PET/CT scanning. There were 19 masses, seven areas of focal 
fl  uorodeoxyglucose (FDG) uptake, two areas of calcifi  cation, one case 
of asymmetry and one area of thickening. In total, 16/30 patients 
underwent breast assessment (11 masses, four focal increased uptake 
and one bilateral calcifi  cation). Out of 11 patients with masses, six were 
proven to have corresponding invasive cancers and two had ductal 
carcinoma in situ. The remaining three were normal or had benign 
disease. Of the four patients with focal increased FDG uptake, one 
patient had invasive cancer, one had a fi  broadenoma and two were 
normal. The bilateral calcifi  cations corresponded to lymph nodes.
Conclusion The incidental detection of breast malignancy by PET/CT 
was signifi  cant at 56%. Breast assessment should be performed in this 
population.
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Image quality and compression force: the forgotten link in 
optimisation of digital mammography?
D O’Leary, T Grant, L Rainford
UCD, School of Medicine and Medical Science, Dublin, Ireland
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Introduction Numerous publications suggest the compression force 
applied in mammography must be reduced to encourage initial/
continued attendance by women. These studies (many with limited 
patient populations) have not used suffi   cient statistical correlation of 
compression force data to image quality to reinforce these contentions. 
The growth of digital mammography has enabled a comparison of 
compression force and image quality in analogue and digital images.
Methods A quantitative and qualitative study of mammography units 
within Ireland collected comprehensive image quality, compression 
(force and depth) and radiation dose data from 4,790 patient images. 
The data were analysed using univariate analysis of variance and SPSS 
statistics including ANOVA to re-examine the connections between all 
parameters for optimisation of mammographic imaging.
Table 1 (abstract P5)
Parameter  Week 1  Week 2  Week 3  Week 4
ADC (×10–3 mm2/s)     
  Fibroglandular tissue  1.7 ± 0.2  1.7 ± 0.3  1.7 ± 0.3  1.7 ± 0.3
T2  (ms)     
  Fibroglandular tissue  57.6 ± 7  58 ± 7  58.7 ± 8  60 ± 10
  Adipose tissue  78 ± 4  77 ± 4  77 ± 4  77 ± 4
Data presented as mean ± SD.
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signifi  cant eff  ects on the image quality; perfect and good images 
consistently required signifi   cantly more compression force than 
moderate and inadequate images. This was especially apparent in 
digital images. The mean compression force (Newtons) required 
to produce a perfect image was: 121.34 N for digital craniocaudal; 
134.23  N for digital mediolateral oblique; 112.23 N for analogue 
craniocaudal; and 129.66 N for analogue mediolateral oblique. Only 
2% of patients expressed dissatisfaction with the higher compression 
forces that were applied.
Conclusion Compression forces are too low, aff  ecting image quality; 
greater compression force by 11 to 15 N is needed to achieve a 
perfect image especially in full-fi  eld digital mammography. Greater 
training of radiographers performing mammography is required 
to standardise the undertaking of the mammographic projections 
with regard to achievable compression depth and the application of 
compression force delivered to the breasts of Irish women attending 
the symptomatic breast services.
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Large-bore vacuum-assisted biopsy of axillary lymphadenopathy
ND Forester1, P Burrows1, A Jack2, A-M Wason1
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Introduction  Lymphoma diagnosis conventionally requires nodal 
excision biopsy, to allow histological subclassifi  cation  of  tumours 
on samples with preserved tissue architecture. As such, diagnostic 
accuracy following 16G or 18G core biopsy is diffi   cult. Large-bore 
vacuum-assisted biopsies, such as Mammotome, can percutaneously 
sample large volumes of breast tissue with excellent tissue architecture 
preservation. We describe vacuum-assisted biopsy of axillary nodes to 
investigate lymphadenopathy in surgically high-risk patients.
Methods Eight patients (seven male, one female; median age 52, range 
27 to 65) underwent ultrasound-guided, 8G vacuum-assisted biopsy 
of axillary lymphadenopathy between March 2009 and February 
2011. The median largest node size was 28 mm (range 14 to 87 mm). 
Three patients had previous ultrasound-guided 18G core biopsies, 
which were insuffi   cient for diagnosis. Between three and 15 cores 
were obtained (median = 7) and sent fresh to the Haematological 
Malignancy Diagnostic Services.
Results  In seven patients, 8G vacuum-assisted biopsy provided 
suffi   cient histologically intact nodal material to be fully diagnostic. In 
one patient, tissue was suspicious for lymphoma, but insuffi   cient for 
fi  nal diagnosis. In seven patients with adequate tissue sampling, six had 
lymphoma and one had reactive lymphadenopathy. Of the lymphoma 
diagnoses, four were new diagnoses (two Hodgkin, one follicular, one 
diff  use large B-cell lymphoma) and two were recurrent lymphomas. No 
procedure-related complications occurred.
Conclusion  Ultrasound-guided large-bore vacuum-assisted biopsy 
can safely biopsy axillary lymphadenopathy. Furthermore, samples 
obtained have suffi   ciently preserved tissue architecture to allow a 
conclusive diagnosis of lymphoma, without requiring surgical intact 
node excision. In our institution, this technique has proved useful in 
high-risk surgical candidates, and where nodal size would have made 
surgery technically diffi   cult.
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Arbitration cancers: analysis from two screening rounds for the 
Coventry, Solihull and Warwickshire screening service
S Garnett
University Hospital, Coventry, UK
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Introduction Third-reader screen-reading is undertaken in our unit to 
reconcile discordant reader results. An audit has been conducted to 
analyse the nature of cancers diagnosed at assessment for arbitration 
recalls. The objective was to identify and describe discordant cancer 
types and appearances.
Methods The study period covered two screening rounds. Arbitration 
records were reviewed and mammographic shape, size, position, 
cancer type and grade, and histological size were recorded. Both fi  lm 
and digital cases were included and compared. Descriptive statistics 
were produced comparing discordant and concordant cancers.
Results A total of 128 arbitration cancers were analysed (3.6% of total 
cancers, n = 3,516). There were 5,635 total arbitrations of which 27% 
(n = 1,519) were assessed. A total of 8.4% were cancer. There were a 
higher number of smaller sized (1 to 15 mm) cancers in the arbitrated 
group, 61% compared with 48% in the concordant group. There was no 
diff  erence between fi  lm and digital cancer size. More cancers appeared 
as lobular, tubular and DCIS in the arbitration group. There was an equal 
spread of calcifi  cation and mass type mammographic appearances.
Conclusion  No previous study had specifi  cally analysed arbitration 
(third-reader) cancers. This audit showed that lesion size is smaller, all 
cancer types are present and both calcifi  cations and masses are equally 
represented. Digital cases did not show any smaller cancers for the 
discordant group. A future audit will be to look at the arbitration interval 
cancers; that is, when two readers have not recalled a subsequent false 
positive case, to assess the features that have been ignored.
P13
Early identifi  cation of substandard breast screening performers
L Dong, Y Chen, AG Gale
Loughborough University, Loughborough, UK
Breast Cancer Research 2011, 13(Suppl 1):P13 (doi: 10.1186/bcr2965)
Introduction  All UK breast screeners can voluntarily undertake the 
PERFORMS scheme, where they examine recent screening cases 
receiving immediate feedback. Once all individuals have participated, 
data are calculated on how they performed compared with peers 
allowing poor performers to be identifi   ed. A way of potentially 
identifying such poor performers much earlier is proposed.
Methods Information from the last round of the PERFORMS scheme 
was reanalysed for which the low performance threshold value was 
known. Data for randomly selected small groups of participants were 
repeatedly bootstrapped with the aim of artifi   cially determining a 
threshold of low performance and comparing this with the known 
actual threshold. Using a varying number from four to 50 participants, 
a sample of 1,000 randomly selected small groups was constructed for 
each number of participants. After bootstrapping each small group, a 
distribution of 1,000 thresholds of low performance was constructed 
and median values and standard errors of this distribution calculated 
to determine how the number of participants aff  ected the estimation 
accuracy.
Results  The standard error of the estimated threshold reduced as 
group size increased, indicating better estimation accuracy. Using data 
from as few as 10 people the artifi  cial threshold approached the known 
actual threshold of poor performance.
Conclusion Individuals who are performing less than their peers on the 
scheme can be identifi  ed early without all screeners having fi  rst taken 
part. Whilst not an absolute outlier measure, this information can be 
fed back in a timely manner, so enabling the individual to improve their 
cancer identifi  cation performance.
P14
Comparison of mammographic fi  ndings and need for ultrasound 
and biopsy in women undergoing wide local excision and either 
intraoperative radiotherapy or external beam whole breast irradiation
A Romsauerova, J Dewar, D Brown, A Evans
Dundee Cancer Centre, University of Dundee, UK
Breast Cancer Research 2011, 13(Suppl 1):P14 (doi: 10.1186/bcr2966)
Introduction TARGIT-A is a recent prospective randomised multicentre 
controlled trial comparing intraoperative radiotherapy (IORT) and 
external beam whole breast irradiation (EB). The aim of this study 
was to compare localised and generalised fi   ndings at follow-up 
mammography and the need for interventions such as ultrasound 
and biopsy between women in the two treatment arms from a single 
recruiting centre.
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with the 63 women who received EB alone. All mammograms were 
reviewed by radiologists blinded to the treatment received. The focal 
soft tissue appearance was classifi  ed. The presence of generalised skin 
thickening and increased density was recorded. The performance of 
ultrasound and/or biopsy was recorded.
Results The number of follow-up mammograms and length of follow-
up was similar in both groups (2.46 IORT vs. 2.09 EB and 3.27 years 
IORT vs. 3.0 years EB). There was no diff  erence in the mammographic 
appearance of the postoperative site between the two groups. 
However, generalised skin thickening and increase in density were 
more common in the EB group compared with the IORT group (20 of 
63 (37%) vs. 10 of 61 (16%), P = 0.04 and 20 of 63 (37%) vs. 5 of 61 (8%), 
P = 0.001, respectively). Ultrasound at follow-up was more frequent in 
the IORT group compared with the EB group (15 of 61 (25%) vs. 7 of 63 
(11%), P = 0.049).
Conclusion  Generalised reactions on mammography are more 
common following EB compared IORT. However, follow-up ultrasounds 
were more frequent in the IORT group.
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Vacuum-assisted core biopsy of the breast
S Saikia, L Lunt
Queen Elizabeth Hospital, Gateshead, UK
Breast Cancer Research 2011, 13(Suppl 1):P15 (doi: 10.1186/bcr2967)
Introduction Vacuum-assisted core biopsy (VACB) is a highly eff  ective 
method of sampling breast tissue. Breast care nurses, at the Queen 
Elizabeth Breast Unit in Gateshead, raised concerns about pain 
experienced by patients during this procedure. The aim of this study 
was to assess how patients perceive VACB.
Methods  Prospective data collection for 6 months from November 
2010 of consecutive patients undergoing VACB. Data were collected 
using a questionnaire about pain experienced immediately and 
4 weeks post procedure, using the Numerical Rating Scale and Short 
Form McGill validated pain scores [1].
Results  Fifty questionnaires were completed. Immediately post 
procedure, 88% felt no or mild pain. Of those reporting pain, 100% 
had a sensory dimension. Four weeks later the memory of the pain 
experienced during the procedure was worse in 46%. In this group, pain 
4 weeks post procedure had an aff  ective dimension in 50% of cases. 
Four weeks post procedure, 91% felt no or mild pain. One hundred per 
cent would reassure a friend about the procedure.
Conclusion Minimal pain was experienced immediately or 4 weeks 
post procedure. There is a discrepancy between pain experienced 
during the procedure compared with the memory of it. The eff  ect of 
the biopsy result could be a contributory factor. Further work linking 
responses to histology may be revealing.
Reference
1. Melzack  R:  The McGill Pain Questionnaire: major properties and scoring 
methods. Pain 1975, 1:277-299.
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Preoperative estimation of the prognosis of invasive breast cancer, 
based on ultrasound size, core biopsy grade and percutaneous 
axillary lymph node biopsy
O Elseedawy, C Purdie, L Jordan, S Vinnicombe, P Whelehan, A Thompson, 
A Evans
Ninewells Medical School, Dundee, UK
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Introduction Assessment of the prognosis of invasive breast cancer 
prior to surgical resection may infl  uence patient management. The 
aim of this study was to calculate the Nottingham Prognostic Index 
(NPI) from preoperative information and compare this with the NPI 
generated by the surgical pathology fi  ndings.
Methods The preoperative Nottingham Prognostic Index (PNPI) was 
calculated in 46 consecutive women undergoing primary surgery 
for invasive breast cancer. The parameters used were imaging size 
(normally by ultrasound), tumour grade on core biopsy, and axillary 
lymph node assessment including core biopsy where appropriate. 
Values were divided into good (<3.41), moderate 1 (3.41 to 4.4), 
moderate 2 (4.41 to 5.4) and poor (>5.4) prognostic groups. Intraclass 
correlation coeffi   cients (ICC) were calculated to compare the PNPI with 
the postoperative NPI.
Results Comparison of the PNPI and NPI gave an ICC of 0.68 (95% CI = 
0.48 to 0.81), indicating fair to good agreement. In 39 of 46 women 
(85%), the PNPI was within one point of the NPI and in 34 (74%) it was 
within 0.5. Thirty women (65%) were assigned to the correct NPI group 
by the PNPI. Twelve (26%) were assigned to the adjacent NPI group. 
In 14 women the NPI group was worse than the PNPI, and in two it 
was better because the tumours were downgraded at postoperative 
pathology.
Conclusion Preoperative estimation of the NPI approximates to the 
defi  nitive NPI in the majority of women studied, and could therefore be 
used to guide systemic treatment decisions preoperatively.
P17
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An audit of breast imaging scoring by radiologists, in cases of 
proven malignancy
JR Powell, B Mucci
Greater Glasgow NHS Trust, Glasgow, UK
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Introduction In 2009 the Royal College of Radiologists Breast Group set 
out a classifi  cation system for breast imaging scoring [1]. A score of 4 
‘suspicious of malignancy’ or 5 ‘highly suspicious of malignancy’ should 
be used ‘in most cases’ of proven breast cancer. However, there is no 
universally accepted target for this in the UK. The American BIRADS 
system suggests a 98% target [2]; however, their scoring system is 
slightly diff  erent.
Methods We examined imaging reports (mammography, ultrasound 
and MRI) of patients diagnosed with a breast malignancy attending 
the symptomatic breast clinic in 2009. Our aim was to determine an 
achievable target for correctly scoring breast imaging.
Results A total of 203 patients’ imaging was examined. One hundred 
per cent of reports included a score. Ninety per cent of the cancers 
were scored 4 or 5. In three underscored cases, radiologist opinion 
was clouded by the fact the patient had had proceeding FNA. Cases of 
cancer recurrence also proved diffi   cult to correctly score.
Conclusion We suggest a target of 90 to 95% of all breast cancers being 
scored 4 or 5. A 95% target is achievable especially if FNA/biopsy is left 
until after imaging has been performed.
References
1. Maxwell  A,  et al.: The Royal College of Radiologists Breast Group breast 
imaging classifi  cation. Clin Radiol 2009, 64:624-627.
2. Liberman  L,  et al.: The Breast Imaging Reporting and Data System. Am J 
Roentgenol 1998, 171:35-40.
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Every second counts: digital and analogue mammography – 
comparison of reading times at the Queen Elizabeth Breast 
Screening Unit, Gateshead, UK
GD Bristow, AJ Potterton, LG Lunt
The Queen Elizabeth Hospital Breast Screening Unit, Gateshead, UK
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Introduction In the NHS Breast Screening Programme (NHSBSP) there 
is a transition to digital mammography following recommendations 
made by the Cancer Reform Strategy [1]. A number of US studies have 
demonstrated that the time taken to interpret digital mammography is 
longer than that for analogue [2,3]. There are no published data about 
this from the NHSBSP.
Methods  Over a 2-month period, 11 readers were timed in their 
interpretation of batched analogue or digital mammograms. These 
were either hung on a multiviewer or preloaded onto Sectra PACS. 
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included in the analysis (unpaired t test), 330 digital and 66 analogue.
Results It takes more time to report a digital mammogram compared 
with analogue (40 ± 1 vs. 35 ± 2 seconds, P <0.05). There is no diff  erence 
in the time taken to report prevalent screens between the analogue 
and digital groups (34 ± 7 vs. 39 ± 2 seconds). The incident screens were 
quicker to interpret as analogue.
Conclusion Our data support the hypothesis that digital interpretation 
is slower than analogue (albeit by 5 seconds) but in the absence of 
needing to compare with previous images there is no diff  erence 
between the two modalities.
References
1.  Cancer Reform Strategy. Department of Health; December 2007.
2.  Berns EA, Edward Hendrik R, Solari M, et al.: Digital and screen-fi  lm 
mammography: comparison of image acquisition and interpretation 
times. Am J Roentgenol 2006, 187:38-41.
3. Haygood  TM,  et al.: Timed effi   ciency of interpretation of digital and fi  lm-
screen screening mammograms. Am J Roentgenol 2009, 192:216-220.
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Introduction In our Trust, in line with NICE guidance, all breast cancers 
undergo preoperative axillary ultrasound and, where indicated, needle 
testing. The current overall sensitivity of this process in our Trust is 
57%. This study investigates tumour size, type and location as possible 
factors for patient triage to repeat preoperative axillary staging, aiming 
to increase our preoperative axillary staging sensitivity.
Methods This prospective study included all patients diagnosed and 
operated on for unifocal breast cancer in our Trust from September 
to December 2010. Descriptive statistics, chi-squared and logistic 
regression were performed upon data collated at MDT meetings.
Results Logistic regression of 101 females implies that as tumour size 
increases by 1 cm, nodal disease risk is 1.75 times larger, with 95% 
confi  dence limits. Comparing tumours <20 mm with those >20 mm, 
nodal disease risk is 5.818 times larger in the >20 mm group (P <0.0005). 
No signifi  cant diff  erence was found in nodal disease risk between the 
histological tumour types, although numbers of lobular and tubular 
carcinomas were small (P = 0.633). Data suggested a diff  erence (0.27× 
smaller risk in UIQ versus UOQ) in probability of axillary node metastasis 
with tumour location with 95% confi  dence limits.
Conclusion This study demonstrates a clear and statistically signifi  cant 
association between tumour size and nodal disease. The data also 
suggest a diff  erence in probability of nodal disease with diff  erent 
tumour location, although increased patient numbers are needed to 
confi  rm this. A larger trial for stratifying patients for single or double 
preoperative staging of the axilla is recommended.
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Can radiation dose in mammography be further reduced by 
increasing the image quality?
D O’Leary, L Rainford
University College Dublin, Ireland
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Introduction Eff  orts to reduce radiation dose should be linked to and 
limited by image quality and the radiation dose should only be lowered 
to levels compatible with image quality for adequate diagnosis; this 
is optimisation of mammography. Despite this link between image 
quality and mean glandular dose (MGD), the MGD is proposed only 
with regard to compression level achieved or population percentile, 
not image quality required/achieved.
Methods A study of symptomatic breast units geographically spread 
over Ireland collected image quality and radiation dose data. The 
quantitative and qualitative data were analysed using mathematical 
modelling and SPSS statistics including ANOVA. High image quality was 
matched to lowest achievable radiation doses; inadequate images were 
discarded from the dataset for recommendations of achievable MGD.
Results MGDs received by perfect images are signifi  cantly lower than 
the radiation doses received by inadequate images. This is seen in both 
digital images and fi  lm-screen images and for both mammographic 
projections: digital craniocaudal, F(3,978) = 2.841, P = 0.37; digital medio-
lateral oblique, F(3,977) = 4.896, P = 0.002; analogue craniocaudal, 
F(3,785) = 7.993, P <0.001; analogue mediolateral oblique, F(3,783) = 
7.961, P <0.001). The mean MGD in mGy required to produce a perfect 
image in each of the categories: digital craniocaudal, 1.23 mGy; digital 
mediolateral oblique, 1.28 mGy; analogue craniocaudal, 2.10 mGy; 
analogue mediolateral oblique, 2.25 mGy.
Conclusion The publication of average glandular dose must be linked 
to image quality achieved and the percentage of inadequate images 
in the data collection must be explicit. The radiation doses can be 
lowered further in digital imaging by greater training of radiographers 
to consistently achieve perfect mammography images.
P22
Audit of accuracy of ultrasound-guided axillary core biopsy
A Anand, R Henderson
Darlington Memorial Hospital, Darlington, UK
Breast Cancer Research 2011, 13(Suppl 1):P22 (doi: 10.1186/bcr2974)
Introduction  Sentinel lymph node biopsy (SLNB) is the preferred 
method of axillary staging in breast cancer. If metastases are detected, 
axillary node clearance (ANC) is necessary. Preoperative detection of 
nodal metastases using ultrasound-guided core biopsy (USCB) allows 
the surgeon to proceed directly to ANC. Negative CBs do not exclude 
metastases. All patients still need SLNB. However, by minimising 
false negatives, unnecessary SLNBs can be minimised. We compared 
our USCB results with the results of subsequent SLNB + axillary node 
sampling (ANS) or ANC to assess our accuracy.
Methods We performed a retrospective audit of patients having USCB 
in primary breast cancer. We included patients presenting to one 
consultant radiologist fi  rm from our unit’s symptomatic breast clinic 
between 27 March 2007 and 7 December 2010. Our criteria for CB 
included cortical thickness >2 mm, loss of fatty hilum and longitudinal 
axis/transverse axis <2. We used a 14G Achieve needle to make four 
passes into the node.
Results Out of 41 CBs, on histology, eight were negative and 33 were 
positive. All positives were proven to be true positive at ANC. Seven out 
of eight negatives were found to be true negative (87.5% true negative) 
at SNB and ANS. One out of eight negative CBs was found to be false 
negative (12.5% false negative) requiring axillary clearance.
Conclusion We found that our results were comparable with published 
recent studies from the UK and abroad. Aggressive and more focused 
sampling could be suggested to further reduce false negatives.
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Introduction This work compares the detection of microcalcifi  cation 
clusters (MC) in digital mammography images with diff  erent image 
quality levels.
Methods A total of 162 normal breast images were acquired on an 
a-Se DR system. MC clusters extracted from magnifi   ed images of 
sliced mastectomies were electronically inserted into half of the 
images. The majority of clusters used were subtle. All images were 
adjusted mathematically using a validated method to simulate the 
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and on both systems at half this dose. Seven experienced observers 
marked the location of suspicious regions, assigning a fi  ve-point score 
for confi  dence that the suspicious region was a cluster. The data were 
analysed using the area under the alternative free-response receiver 
operating characteristic (AFROC) and the area under the receiver 
operating characteristic (ROC) as fi  gures of merit.
Results  There was a signifi   cant reduction in detection using CR 
compared with DR; the AFROC area decreased from 0.83 to 0.63 and 
the ROC area decreased from 0.91 to 0.79 (P <0.0001). A signifi  cant 
reduction in detection was also evident at half the original dose for 
both DR and CR.
Conclusion The detection of subtle clusters was reduced signifi  cantly 
with CR compared with DR and it is possible that CR will miss cancers 
manifesting as microcalcifi   cation that would be found by DR. 
Calcifi  cation detection was sensitive to the dose used, which should be 
refl  ected in image quality standards to ensure adequate image quality 
is achieved even at the cost of a higher dose.
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Improving the validity of breast density assessment
A Eadie, P Whelehan, L Baker, J Berg, A Evans
University of Dundee, UK
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Introduction  As the importance of mammographic density in risk 
stratifi  cation and breast cancer research continues to grow, density 
assessment must be rigorous. Area-based human visual density 
assessment will continue until software is fully validated. Locally, having 
reviewed the literature, we chose two tools and sought to establish that 
these would give meaningful results in our hands for comparison with 
other data.
Methods  In 50 mammograms, four observers each estimated the 
percentage dense area, recorded on a 100 mm visual analogue scale 
(VAS). On a separate occasion, each observer also assigned BIRADS 
density scores. The process was repeated with a minimum interval of 
1 week. Observers were blinded to each others’ scores and their own 
previous scores. Viewing parameters were standardised.
Results BIRADS Intra-rater agreement: Observers 1, 2 and 4, intraclass 
correlation coeffi     cient (ICC) and lower 95% confi   dence bound all 
above 0.8 (excellent agreement); below 0.8 for Observer 3. Inter-rater: 
Observers 2 and 4, ICC = 0.97, 95% CI = 0.95 to 0.98; Observers 1 and 3 
with any other, ICC below 0.8.
Percentage Intra-rater agreement, ICC for all observers >0.9 with lower 
confi  dence bound >0.8. Inter-rater: Observers 2 and 4 and 2 and 3, ICC 
and lower confi  dence bound >0.8; all other pairs, <0.8.
Conclusion Intra-observer and inter-observer agreement in mammo-
graphic density assessment varies. Percentage dense area estimation 
using a VAS appears more reproducible than the BIRADS classifi  cation. 
This simple study enabled selection of the most reliable observers and 
we recommend that other centres undertaking scientifi  c studies where 
mammographic density is a relevant variable perform similar audits to 
maximise outcome measure validity.
P25
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preoperative imaging of lobular carcinoma?
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Introduction Digital breast tomosynthesis (DBT) is an emerging breast 
imaging technique which we have shown in our institution to more 
accurately size tumours when compared with 2D mammography. 
In this study we have looked at the accuracy of DBT in the sizing of 
invasive lobular carcinoma (ILC) when compared with MRI, the current 
imaging technique of choice.
Methods  All clients diagnosed with ILC were identifi  ed  between 
December 2008 and March 2010. Of these clients, those who had 
undergone imaging with both MRI and DBT were extracted. Tumour 
diameter in the single largest dimension was recorded on DBT by 
two consultant radiologists. MRI and pathological tumours sizes were 
extracted from the notes. The agreement between the two imaging 
modalities and pathology was analysed using the methods described 
by Bland–Altman. Pearson correlation coeffi   cients were calculated.
Results Twenty-three cases of lobular carcinoma were identifi  ed with 
MRI and DBT imaging. Pearson correlation coeffi   cients for DBT with 
pathology r = 0.73, MRI with pathology r = 0.86, MRI with DBT r = 0.81. 
See Table 1.
Table 1 (abstract P25)
 DBT–pathology    MRI–pathology
Upper limit of agreement (mm)  31 (15 to 47)  25 (12 to 38)
Mean diff  erence (mm)  –11 (–20 to –1)  –9 (–16 to –2)
Lower limit of agreement (mm)  –52 (–68 to –36)  –43 (–56 to –30)
95% CI presented in parentheses.
Conclusion The study shows that MRI is superior to DBT in predicting 
the histological size of lobular carcinoma although there is disparity 
with both techniques. With the advent of contrast-enhanced 2D 
mammography, we hope for the future development of contrast-
enhanced DBT to give us a technique that will be comparable with MRI.
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Comparison of dedicated digital specimen radiography with direct 
digital specimen mammography images
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Introduction The objective was to compare the image quality obtained 
from a dedicated specimen modality with the image quality from a 
standard direct digital mammography unit.
Methods  All wide local excision (WLE), vacuum-assisted 10G core 
biopsy and 14G core biopsy samples were imaged with a Hologic 
Dimensions mammography unit and a Bioptics Biovision digital 
specimen radiography system. WLE specimens were imaged without 
magnifi  cation on both systems. Biopsy specimens were imaged with 
magnifi  cation. Two readers assessed each set of images. The number 
of microcalcifi  cations was recorded and visibility of each lesion was 
assessed on a four-point scale.
Results The total number of specimens was 97. Of these specimens, 
67 contained microcalcifi  cation, 23 masses, four distortions and three 
masses with calcifi  cation. In 44/67 specimens, the Biovision system 
demonstrated >20 microcalcifi  cations as opposed to only 24/67 with 
the Hologic system; this is shown to be signifi  cant with P = 0.001. In two 
of the specimens no calcifi  cation was demonstrated on the Hologic 
system, whereas the Biovision system demonstrated <5 in these cases. 
A signifi  cant diff  erence was also shown in the conspicuity of the lesions 
between the two systems, with the lesions having greater conspicuity 
on the Biovision system (P = 0.027).
Conclusion  Signifi   cantly more microcalcifi   cation is demonstrated 
by the Biovision system and conspicuity is signifi  cantly better. This 
provides increased confi  dence that a representative sample has been 
obtained at biopsy, and therefore increased diagnostic confi  dence.
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Cross-Atlantic diff  erences in reading the same breast screening 
cases
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Introduction American breast screening radiologists typically read a 
lower annual volume and recall more cases than their UK counterparts. 
This study investigated what happens when experienced breast 
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case set, albeit using diff  erent resolution displays.
Methods Sixteen experienced American breast screening radiologists 
interpreted 40 diffi   cult FFDM cases containing various mammographic 
features, excluding small calcifi  cations, using dual 202 DICOM calibrated 
monitors. For comparison purposes, the anonymous data were used 
of 16 experienced UK breast radiologists who had read the same 
cases as part of the PERFORMS scheme using clinical mammographic 
workstations.
Results The 16 American radiologists were split into two groups of low 
volume (<5,000 cases p.a.) and high volume (≥5,000 cases p.a.) and 
performances were compared. There was no signifi  cant diff  erences 
(t = 0.23, P  >0.05). Consequently their performance data were 
combined and compared with those of the 16 UK radiologists. There 
was no signifi  cant diff  erence between the two groups in correct recall 
decisions (UK, 97.1%; USA, 92.9%; t = 0.042, P >0.05) although there 
were signifi  cant diff  erences in correct return to screening decisions (UK, 
88.9%; USA, 80%; t = 0.089, P <0.05) and the number of malignancies 
detected (UK, 98.7%; USA, 93%; t = 0.049, P <0.05).
Conclusion The use of lower resolution monitors (approximately half 
that of a mammographic workstation) by the American group was 
off  set by their experience (>15 years) such that even very experienced 
but low-volume readers performed well. Whilst the UK group overall 
performed better on these cases, the American group still recalled 
more, refl  ecting their real-life screening criteria.
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Introduction  Digital breast tomosynthesis (DBT) has the potential 
to improve the accuracy of standard digital mammography (DM) [1]. 
The TOMMY Trial is a multicentre, multireader, retrospective matched 
comparison of the diagnostic performance of DBT and DM.
Methods  Study population Women (47 to 73 years old) recalled 
for further assessment after routine breast screening and women 
<50 years with a family history of breast cancer, attending annual 
mammographic screening. Intervention  Women who consent to 
participate in the trial undergo standard two-view DM and DBT 
imaging of both breasts. Images are acquired in a single examination 
under the same degree of breast compression on a commercially 
available (Hologic) digital mammography system. Outcome measures 
The primary outcome measure is the relative sensitivity and specifi  city 
of DM and DBT in the detection of early-stage cancers and subtle 
lesions, particularly in women with dense breasts. This will be evaluated 
in a retrospective reading study where readers at each centre conduct 
blinded independent reviews of anonymised DM, or DBT, or DM and 
DBT images of cases from other centres.
Results  The trial set-up has involved lengthy and complex legal 
negotiation with collaborating sites, the equipment manufacturer and 
the grant-awarding body. Designated readers from each centre have 
completed tomosynthesis training and recruitment has commenced.
Conclusion It should be noted that the negotiation of contracts and 
commercial agreements adds a considerable time burden to the set-up 
phase of multicentre trials.
Reference
1.  Dobbins JT,Godfrey DJ: Digital X-ray tomosynthesis: current state of the art 
and clinical potential. Phys Med Biol 2003, 48:R65-R106.
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Introduction Although ultrasound is considered to be a poor screening 
tool, it is reported to be useful in detecting multifocal cancers [1]. This 
study aims to look at the use of bilateral whole breast ultrasound in 
detecting clinically and mammographically occult breast cancers.
Methods  All patients presenting to symptomatic clinic in Basildon 
Hospital underwent sonographer-performed bilateral whole breast 
ultrasound before the year 2010. All breast cancer patients in 2009 
whose imaging details are available on the Radiology Management 
System (RMS) and PACS are the materials of this study (number of 
patients: 101). Clinical and imaging details were evaluated on RMS and 
PACS and cases in which cancer was detected only by ultrasound were 
identifi  ed.
Results  Among the 101 patients, multifocal cancers were detected 
in ipsilateral breast in two patients. Both of these patients had one 
clinically and mammographically detected cancer. The second 
smaller lesion was depicted only on ultrasound. Apart from the above 
multifocal cancers, there was no case in which cancer was identifi  ed 
only on ultrasound.
Conclusion  Operator-performed bilateral whole breast ultrasound 
is useful in detecting multifocal primary breast cancer although its 
routine use in all the patients is yet to be proven.
Reference
1.  Wilkinson LS, Given-Wilson R, Hall T, Potts H, Sharma AK, Smith E: Increasing 
the diagnosis of multifocal primary breast cancer by the use of bilateral 
whole-breast ultrasound. Clin Radiol 2005, 60:573-578.
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Introduction In our institution, 30% of screen-detected DCIS diagnosed 
by 14G core biopsy will be upgraded to invasive carcinoma at 
defi  nitive surgery, necessitating subsequent sentinel node procedure 
to complete staging. This could be decreased by fi  rst-line large-bore 
vacuum-assisted biopsy. Prior to introducing this, we reviewed patient 
factors, aiming to identify subsets of patients who may benefi  t from 
fi  rst-line vacuum-assisted biopsy.
Methods A retrospective review of B5a diagnoses at initial biopsy, April 
2009 to March 2010. Univariate and multivariate logistic regression 
analysis was performed to analyse the impact of patient, radiographic 
and histological factors on the B5b upgrade rate.
Results  A total of 51 patients had DCIS diagnosed on initial core 
biopsy. Fifteen were upgraded to invasive carcinoma following surgical 
excision. No association between patient age, screening round, grade 
of DCIS, calcifi  cation pattern (focal vs. diff  use) and ER/PR status was 
found. Mammographic calcifi   cation size did signifi  cantly  predict 
upgrade in univariate analysis (OR = 1.04 per mm increase in size of 
calcifi  cation; 95% CI = 1.01 to 1.07; P = 0.02) and in multivariate analysis 
when adjusting for patient age and calcifi  cation pattern (OR = 1.04; 
95% CI = 1.00 to 1.07; P = 0.043). Stratifi  cation of mammographic 
calcifi  cations showed that clusters >20 mm in size have 16.6 times the 
odds of upgrade compared with calcifi  cations <10 mm (95% CI = 1.38 
to 200.02; P = 0.027).
Conclusion  Size of calcifi  cations on mammography is a signifi  cant 
predictor of upgrade to invasive carcinoma. Increases in calcifi  cation 
of 10 mm increase the odds of upgrade to invasive carcinoma by 34%. 
Given the signifi  cantly increased upgrade rate for calcifi  cations over 
20 mm, fi  rst-line vacuum-assisted biopsy in this subset of patients at 
initial screening assessment may prove cost-eff  ective.
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Introduction In the UK, MRI is mostly used to stage needle biopsy 
proven cancer. Less often it is used in problem-solving when there is 
no proven malignancy. We reviewed its use as a problem-solver after 
mammographic screening.
Methods NHS screening patients who attended assessment between 
December 2008 and July 2011 and had contrast-enhanced MRI within 
3 months were identifi  ed. Fourteen out of 47 did not have the MRI as 
staging, and were reviewed.
Results (1) Mammography, ultrasound and/or core biopsy pathology 
were felt to be discordant in seven cases. MRI confi  dently excluded 
malignancy in fi  ve. Two had surgery, fi  nding a complex sclerosing 
lesion in one and a reactive lymph node in the other. (2) Clinical concern 
was not matched by mammography and ultrasound in four cases. MRI 
confi   dently excluded malignancy in three but found an otherwise 
occult cancer in the fourth. (3) Core biopsies were technically diffi   cult in 
two cases. MRI confi  dently excluded malignancy in one and the other 
was benign on excision. (4) One patient had proven cancer in one breast 
not needing staging. Screening also showed microcalcifi  cations with a 
possibly nonrepresentative normal core biopsy in the other breast. MRI 
was suspicious and this was also cancer at diagnostic surgery.
Conclusion  MRI, used selectively, was useful in problem-solving at 
screening assessment. When it was negative, this meant some patients 
could be reassured without surgery. It was useful where there was 
clinical suspicion but normal conventional imaging.
P32
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Introduction Axillary ultrasound staging with core biopsy (CB) or fi  ne 
needle aspiration (FNA) in primary breast cancer is well established. 
Negative patients will have a sentinel lymph node biopsy (SLNB). 
This study compares the initial ultrasound fi  nding versus fi  nal axillary 
histology in patients undergoing SLNB.
Methods A total of 249 breast carcinoma patients, who underwent 
SLNB between August 2007 and January 2011, were included. Axillary 
ultrasound and histology results were reviewed. Ultrasound fi  ndings 
and any subsequent biopsies were recorded in positive and negative 
SLNB groups. The axillary lymph node biopsy histology slides were 
reviewed in the false negative axillary ultrasound biopsy/FNA group.
Results  Of 249 patients, 191 (76.7%) were SLNB-negative and 58 
(23.3%) were SLNB-positive. Thirty out of 191 (16%) patients without 
axillary metastases had ultrasound-guided sampling. Two out of 
191 did not have ultrasound-guided sampling as the procedure was 
deemed unsafe. Twelve out of 58 (21%) SLNB-positive patients had 
abnormal ultrasound appearances; 8/12(67%) had CB and 4/12 (33%) 
had FNA, not signifi  cantly  diff   erent to the CB/FNA rates in SLNB-
negative patients (24/32 (75%) and 6/32 (25%), respectively; P = 0.2). 
See Figure 1. Review of 12 false negative histology slides revealed 1/12 
(8%) had micrometastasis and 11/12 (92%) were benign.
Conclusion There are no signifi  cant diff  erences in the rate of axillary 
ultrasound abnormality between SLNB-positive and SLNB-negative 
patients. This suggests that ultrasound nodal abnormalities due to 
malignancy are probably being diagnosed by ultrasound-guided 
sampling and do not progress to SLNB. It also supports SLNB for 
sonographically abnormal lymph nodes as opposed to axillary nodal 
dissection, as many of these patients will not have metastases, if USS 
sampling is negative. Our small study has not shown signifi  cant benefi  t 
of CB over FNA in axillary staging. We found a low upgrade rate on 
reviewing original ultrasound-guided histology slides, supporting 
current pathology techniques.
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Introduction  The Royal College of Radiologists Breast Group has 
formalised the UK fi  ve-point breast imaging scoring system to encourage 
uniformity of reporting. The Breast Imaging and Reporting Data System 
(BI-RADS) is widely used throughout North America and Europe, and, 
unlike the UK scoring system, each BI-RADS category has an associated 
cancer likelihood. This study aims to quantify the cancer likelihood 
of each of the UK categories and map them to comparable BI-RADS 
categories to facilitate comparison of reporting, research and literature.
Methods Between January 2001 and December 2008, mammograms 
and ultrasounds performed in a symptomatic setting were 
prospectively UK scored and the percentage of cancer outcomes within 
each group calculated. These were then compared with the percentage 
incidence of the BI-RADS categories.
Results Of 23,741 separate assessment episodes, 15,288 mammograms 
and 10,642 ultrasound examinations were evaluated. There was direct 
correlation between UK scoring and BI-RADS for categories 1 and 5. UK 
score 2 lipomas and simple cysts correlated with BI-RADS 2, with the 
remaining UK score 2 lesions (mostly fi  broadenomas) assigned to BI-
RADS 3. BI-RADS 4 incorporates a wide range of cancer risk (2 to 95%) 
with subdivisions a, b and c indicating increasing, but unspecifi  ed, 
likelihood of malignancy. UK score 3 correlated with BI-RADS 4 a/b and 
UK score 4 corresponded with BI-RADS 4c.
Conclusion The cancer likelihood of the UK scoring has been quantifi  ed 
and mapped to the appropriate BI-RADS categories with equivalent 
Figure 1 (abstract P33).
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practice on an international scale.
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Introduction  Routine MRI in the assessment of lobular carcinoma, 
invasive ductal carcinoma in dense breasts, patients younger than 
35 or radioclinical discordance at the time of cancer diagnosis was 
introduced in the symptomatic breast unit of Ealing Hospital in 2009. 
We analyse the impact of this new pathway on our local practice.
Methods All patients with a new diagnosis of breast cancer in two 
periods of 18 months, before and after the introduction of MRI, were 
reviewed. Mastectomy rates were compared between the two groups 
and the role of MRI in this change is discussed. The cost of the new 
pathway is reviewed, including the cost of additional imaging and 
biopsies generated by MRI.
Results The mastectomy rate increased from 25% between 1 January 
2006 and 30 June 2007, to 40% between 1 January 2010 and 30 June 
2011. Other factors (patient group, cancer grade, multidisciplinary team 
decision-making process) were unchanged. The cost of the presurgical 
assessment of patients undergoing MRI has increased signifi  cantly.
Conclusion  Presurgical MRI has changed the fi  rst-line  treatment 
off   ered by our team, but at a signifi   cant cost, especially for the 
radiology department. The local impact on overall survival and event-
free survival is still unknown.
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Introduction The Leeds breast service treats over 500 breast cancers 
a year. The general practitioners (GPs) have always had access via the 
one-stop breast clinic or direct access to the imaging department. 
Any positive imaging fi  ndings are actioned within imaging and the 
patients are referred to the clinic for results. The GP is informed. With 
the introduction of 2WW it is appropriate to re-audit this practise.
Methods This is a retrospective audit performed over a 6-month period 
using the radiology database (CRIS) and the clinical database (PPM). 
The data collected included the number of GP referrals, the imaging 
performed, the number of biopsies and the number of referrals to the 
breast clinic. The timeline for each patient was recorded and the costs 
involved where compared with referral to the one-stop clinic.
Results A total of 592 patients were referred direct to imaging from 
1 July 2010 to 31 December 2010. The GP referrals were seen within 
an average of 23 days (3 to 47 days). A total of 223 patients had 
mammography and ultrasound, 165 had mammography only and 
204 had ultrasound only. Twenty-six patients had biopsies; 45% were 
performed at the same attendance. Nine cancers were diagnosed. 
Forty-one patients were referred to the one-stop clinic. The radiology 
department received payment per procedure compared with a 
standard percentage per patient.
Conclusion  The one-stop clinic with triple assessment is the gold 
standard. GP direct access still safely reduces the burden of a 2-week 
wait provided robust pathways are in place to ensure prompt biopsy 
and appropriate referral to the breast clinic.
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Introduction It is accepted that a proportion of patients treated by 
breast-conservation surgery for unifocal malignancy will undergo 
further surgery for residual disease. Preoperative planning for 
impalpable lesions involves a radiological prediction of the extent 
of disease. The optimal outcome is disease clearance achieved by 
one operation only. We have revisited our cases which required a 
subsequent theatre visit in order to facilitate an understanding of 
the factors involved in accurate lesion sizing and thereby reduce re-
excision rates.
Methods  All women screened through the Wrexham centre with 
a positive diagnosis of in situ or invasive disease going on to have 
operative treatment over a 1-year period have been included. The 
lesions were double-read by experienced fi   lm readers to obtain a 
maximal dimension on two-view mammography and ultrasound 
where applicable. Each case was attributed a grading, 1 to 3, for ease 
of measurement. This was compared with the postoperative histology, 
reported by a specialist breast histopathologist. The size, type, grade, 
receptor status and nodal status were recorded for each case.
Results A total of 61 cases were selected. The preoperative prediction 
of size was closest to the mammographic measurement in 74% of 
cases, and to the ultrasound dimension in 21%. The remainder showed 
equal measurements on both.
Conclusion The mammogram provides a more accurate prediction of 
lesion size when compared with ultrasound images. It should be borne 
in mind that a certain proportion of women will choose mastectomy 
over conservation regardless of the available option of conservation.
P38
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Introduction  Symptomatic mammogram machines in trusts that 
do not run screening services are rarely used by the National Breast 
Screening Service. This is a potential untapped site for screening. This 
study surveyed whether women attending current screening sites 
would go to hospital-based symptomatic units instead.
Methods  All women who attended NHS breast screening in fi  ve 
diff  erent sites in South East England were surveyed over 1 day. One 
site was at the screening centre. The others were mobile, two being 
rural and two urban. Home postcodes were used to calculate how far 
women had travelled and the distance to the nearest symptomatic 
unit. This was correlated with a questionnaire about mode of transport 
and whether the women would be ready to attend screening at a 
symptomatic unit.
Results Women at four of the sites said they would just as likely to attend 
their local hospital for screening. This included one of the rural sites, 
where the average women would have had to travel no further to her 
local hospital. The fi  fth site was also rural but here most women would 
have to travel more than 15 miles to the hospital, and most had travelled 
less than 5 miles to the mobile unit. One woman in three would be less 
likely to attend screening at the local hospital than this site.
Conclusion Women going for screening would be happy to have this 
in their local hospital symptomatic unit as long as this did not entail 
extra travel.
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Introduction  Occult breast carcinoma presenting with axillary 
lymphadenopathy is an uncommon but diffi   cult clinical problem. The 
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form of treatment may be uncertain. To answer these questions, we 
have examined the outcomes of women presenting in this way over a 
number of years.
Methods  Thirteen women were identifi  ed prospectively over a 12-
year period, presenting with suspicious lymphadenopathy but no 
identifi   able breast tumour on initial mammography or ultrasound. 
Biopsy of the abnormal nodes was consistent with a breast primary in 
all cases. All women had further imaging with breast MRI (11 cases), 
breast scintigraphy (one case) and CT scanning of the chest and 
abdomen. Second-look ultrasound was targeted to suspicious areas 
identifi  ed on second-line imaging. The type of treatment, presence of 
distant metastases and survival were recorded.
Results  Further imaging revealed a primary breast lesion in seven 
cases, six remained truly occult. Follow-up ranged from 3 to 144 
months (mean 38 months). Three patients died, one is alive with distant 
metastases and nine remain disease free. Those with no identifi  able 
primary were treated with chemotherapy usually in combination with 
radiotherapy.
Conclusion The use of MRI and targeted ultrasound-guided biopsy 
revealed primary tumours in approximately half our cases presenting 
with lymphadenopathy and negative conventional imaging. 
Chemotherapy with radiotherapy appears to be an eff  ective treatment 
for occult breast cancer. The initial staging tests are crucial and if clear 
the prognosis appears similar to patients with breast cancer and 
positive axillary nodes.
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Introduction Lobular carcinoma is frequently atypical on conventional 
imaging. MRI has increasingly been used to evaluate lobular carcinoma 
in recent years. Our experience has been that lobular MRI fi  ndings 
are also relatively diffi   cult to interpret. In this study we aim to defi  ne 
lobular MRI characteristics to aid preoperative staging accuracy.
Methods This retrospective study included all lobular breast cancers 
which were subjected to preoperative MRI in our Trust from May 2010 
to May 2011. Radiologists blinded to the original MRI reports used a 
questionnaire based on BIRADS to describe the fi  ndings. Final surgical 
histology was used as the gold standard for comparison. Descriptive 
statistics were performed on data obtained.
Results Full imaging and fi  nal surgical histology was available for 24 
ladies with lobular carcinoma. In 83% (20/24) of cases the MRI tumour 
morphology was of a mass (19/20 irregular mass). Mass enhancement 
varied: heterogeneous 50% (10/20), homogeneous 40% (8/20). MRI 3D 
reconstruction gave the largest measurement most frequently (11/24), 
but the third post-contrast sequence most frequently (8/24) provided 
the most accurate tumour measurement. Enhancement curves were 
type 2 in 15/24 cases. In 21/24 cases the question of MRI multifocality 
correlated with fi  nal surgical histology. A total of 12.5% (3/24) patients 
had contralateral lesions identifi  ed by MRI.
Conclusion The most common lobular cancer morphology on MRI is 
an irregular mass with heterogeneous, type 2 enhancement. When 
compared with surgical histology, the third post-contrast (coronal) 
sequence gave the most accurate tumour measurement most 
frequently, with 3D reconstruction providing an overestimate in some 
cases.
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Introduction The one-stop model was introduced into the oncology 
follow-up clinic for breast cancer patients at Ealing Hospital in 
November 2010. We present why and how this change was introduced, 
and assess the impact on radiology practice during the fi  rst 6 months. 
We also present the results of our fi   rst patient satisfaction survey 
completed by those attending the new clinic. 
Methods A customer survey was completed by 50 patients attending 
the new follow-up clinic over a 2-month period. The impact on 
radiology practice was also assessed
Results A total 100% of patients preferred the new follow-up system, 
and organisational changes to the work fl  ow were implemented with 
no signifi  cant additional cost.
Conclusion  The one-stop approach is preferred by breast cancer 
patients at all stages of their care, not just at diagnosis. Patients can 
benefi  t from this system with minimal additional cost burden.
P43
Use of ultrasound elasticity imaging to monitor the response of a 
primary breast cancer to neoadjuvant chemotherapy in one patient 
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Introduction  Neoadjuvant chemotherapy is used as the primary 
treatment for locally advanced breast cancer to reduce tumour size 
and protect against metastatic spread. Monitoring the response to 
chemotherapy is achieved mainly by clinical assessment, which may 
prove unsatisfactory. This proof-of-principle study is to determine 
if changes of size and texture in the elastogram can track tumour 
response.
Methods A young woman with an invasive ductal carcinoma, visible on 
mammography and ultrasound (US), was treated with seven cycles of 
chemotherapy. Diagnostic mammography, MRI and core biopsy studies 
were performed. B-mode US and elastography datasets were collected 
in two planes prior to each cycle using a coarse calcifi  cation within the 
tumour as a constant reference point. Seven sequential strain images, 
each 3 weeks apart, were collected in total. The ratio of tissue strain 
within and outside the mass was calculated as an indicator of tumour 
response. The fi  ndings were compared with the post-chemotherapy 
MRI and mastectomy histology.
Results The tumour showed almost complete histological response 
to chemotherapy. Sequential elastography studies demonstrated 
signifi  cant ratio changes in stiff  ness in tumour and peritumoral areas.
Conclusion Preliminary results suggest the changes in tumour and 
peritumour stiff   ness caused by chemotherapy are detectable by 
ultrasound elastography. Further investigation is required to evaluate 
the potential of elastography as a monitoring tool for chemotherapy 
treatment.
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Introduction Breast cancer constitutes 21% of all cancer cases and 
ranks third according to cancer type in Kenya. Mammography therefore 
remains a powerful radiographic imaging technique for detecting 
and managing breast cancer. However, the active and radiosensitive 
glandular tissue calls for the need for an eff  ective quality assurance 
programme.
Methods  A questionnaire method was developed and used in 
recording the displayed patient dose, compressed breast thickness and 
exposure factors. The average glandular dose, device performance, and 
fi  lm quality grading were also carried out at the largest mammography 
facility in Kenya.
Results There were 3,264 fi  lms from 1,252 women of between 25 and 
90 years old. The AGD per fi  lm was 2.14 (range 0.27 to 9.43) mGy for 
the CC projection and 2.44 (range 0.20 to 10.12) mGy for the MLO 
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above the recommended 3 mGy diagnostic reference level.
Conclusion In view of the diagnostic dose fi  nding of this study, the 
variation of mammography imaging techniques revealed the need for 
standards and optimisation of mammography practice in Kenya.
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Introduction  Recent guidelines advise that mammography should 
only be off  ered to women between the ages of 35 and 39 if clinical 
examination raises concern or a targeted ultrasound of the breast 
reveals a suspicious abnormality [1]. The aim of this study was to assess 
the role of mammography as a diagnostic tool in women aged 35 to 39 
presenting to the symptomatic breast clinic.
Methods All women aged between 35 and 39 years presenting to the 
symptomatic breast clinic between April 2010 and March 2011 were 
eligible for inclusion. Data were collected on demographics, presenting 
symptoms, radiological investigation and diagnosis.
Results  A total 112 of 124 women identifi   ed had mammography 
performed as part of their initial assessment; one woman presented 
with a solid lump which was indeterminate on ultrasound but proved 
to be breast cancer on biopsy. The majority of patients were diagnosed 
with mastalgia, benign nodularity or fi   broademona. Core biopsies 
confi  rmed benign pathology in eight women. Of the 12 women who 
did not have mammography, benign pathology was diagnosed using 
clinical examination and ultrasound, with breast cysts and sepsis being 
the commonest causes of pathology.
Conclusion  The role of mammography in women aged 35 to 39 
presenting to the symptomatic breast clinic should be reassessed. Our 
data support the guidelines that ultrasound is the imaging method of 
choice in this age group.
Reference
1.  Willett AM, Michell MJ, Lee MJR, editors: Best Practice Diagnostic Guidelines for 
Patients Presenting with Breast Symptoms. Department of Health; November 
2010 [http://www.associationofbreastsurgery.org.uk/Content/Guidelines.
aspx].
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Introduction  Vacuum-assisted biopsies (VABs) are used for both 
diagnostic and treatment purposes. Currently there are no set 
guidelines in our department as to who should proceed to a VAB. The 
purpose of this study is to analyse the indication for a VAB, the upgrade 
or downgrade rate when compared with the initial core biopsy and the 
overall fi  nal outcome of these patients.
Methods A retrospective search of all VABs performed from 1 April 
2009 to 31 March 2010 was identifi  ed. The indication for VAB, the initial 
core biopsy results and the vacuum biopsy results and fi  nal outcomes 
were recorded.
Results A total of 37 VABs were performed within the year. Two were 
for treatment excision of fi  broadenoma. A total of 35 were diagnostic 
VABs. Three went straight to vacuum biopsies due to either a small 
lesion or suspicion for a recurrent malignancy. Of the remaining 32 
cases, 21 were for indeterminate M3/U3/B3 lesions, fi  ve for clinical and 
pathological mismatch, three for further clarifi  cation of core biopsy 
result, two for staging the extent of the tumour, and one for inadequate 
core biopsy. Thirteen out of 32 (40.6%) were upgraded from the initial 
biopsy, 10 proceeded to further procedures. Six out of 32 (18.8%) 
remained the same grade, two (33.3%) required further procedure. 
Thirteen out of 32 (40.6%) were downgraded, fi  ve (38.5%) proceeded 
to further procedures.
Conclusion Our audit has shown VAB is useful in providing a defi  nitive 
diagnosis in a range of breast pathology, in particular B3 lesions. We 
therefore strongly advise its use in cases of pathological uncertainly to 
save patients from further unnecessary interventions.
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Introduction The purpose of this study was to analyse assessment of 
the axilla in patients with primary operable breast cancer in a one-stop 
symptomatic breast unit.
Methods  A retrospective review of 229 patients diagnosed with 
new primary operable breast carcinoma over a 12-month period. All 
patients underwent axillary ultrasound (US). All cases with normal US 
had subsequent sentinel lymph node biopsy (SLNB). All cases with 
abnormal US underwent fi   ne needle aspiration cytology (FNAC). 
Findings were correlated with SLNB and axillary node clearance 
histology.
Results A total of 128 patients had normal US and subsequent SLNB, 
this was positive in 29 (23%); 12 (40%) had micro metastases; primary 
tumour size was >2 cm in 22 (76%). Positive predictive value for US 
and FNAC was 97%. Negative predictive value was 75%. False positive 
and negative rates for US axilla are discussed with analysis of tumour 
subgroups and pattern of positive nodes.
Conclusion The combination of US and FNAC is a powerful predictive 
tool of axillary disease [1]. Disappointingly false negative axillary US did 
not correlate solely with micro metastases. This may refl  ect a learning 
curve eff  ect, and will be reassessed on follow-up data.
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